Trial Profile
Corifollitropin Alfa Compared to Daily Rec FSH in Poor Responders Undergoing ICSI Using a GnRH Antagonist Protocol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Choriogonadotropin alfa; Follitropin beta; Ganirelix
- Indications Ovulation disorders
- Focus Therapeutic Use
- 25 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrial.gov record.
- 05 Mar 2014 New trial record